Literature DB >> 9226901

Actinomyces europaeus sp. nov., isolated from human clinical specimens.

G Funke1, N Alvarez, C Pascual, E Falsen, E Akervall, L Sabbe, L Schouls, N Weiss, M D Collins.   

Abstract

Ten strains of a hitherto undescribed catalase-negative, facultatively anaerobic, coryneform bacterium were isolated or collected by workers at three European clinical bacteriology laboratories or reference centers. These strains were isolated from humans, and most came from abscess material. Biochemical and chemotaxonomic characterization revealed that the strains belonged to the genus Actinomyces. The phenotypic features of the 10 strains were incompatible with the descriptions of the previously established Actinomyces species. A comparative 16S rRNA gene sequence analysis demonstrated that the previously undescribed strains constitute a new line in the genus Actinomyces. The name Actinomyces europaeus sp. nov. is proposed for these clinical isolates. The type strain is CCUG 32789A.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9226901     DOI: 10.1099/00207713-47-3-687

Source DB:  PubMed          Journal:  Int J Syst Bacteriol        ISSN: 0020-7713


  26 in total

1.  Development of amplified 16S ribosomal DNA restriction analysis for identification of Actinomyces species and comparison with pyrolysis-mass spectrometry and conventional biochemical tests.

Authors:  V Hall; G L O'Neill; J T Magee; B I Duerden
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

2.  Phenotypic identification of Actinomyces and related species isolated from human sources.

Authors:  N Sarkonen; E Könönen; P Summanen; M Könönen; H Jousimies-Somer
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

3.  Identification of clinical isolates of actinomyces species by amplified 16S ribosomal DNA restriction analysis.

Authors:  V Hall; P R Talbot; S L Stubbs; B I Duerden
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

4.  Evaluation of four commercial test systems for identification of actinomyces and some closely related species.

Authors:  Anne-Marie Santala; Nanna Sarkonen; Val Hall; Petteri Carlson; Hannele Jousimies-Somer; Eija Könönen
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

5.  Characterization of some actinomyces-like isolates from human clinical sources: description of Varibaculum cambriensis gen nov, sp nov.

Authors:  Val Hall; Matthew D Collins; Paul A Lawson; Roger A Hutson; Enevold Falsen; Elisabeth Inganas; Brian Duerden
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

6.  In vitro activity of quinupristin and dalfopristin in combination and alone against coryneform bacteria.

Authors:  G Funke; R Troxler
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-11       Impact factor: 3.267

7.  First description of Curtobacterium spp. isolated from human clinical specimens.

Authors:  Guido Funke; Max Aravena-Roman; Reinhard Frodl
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

8.  Subcutaneous fistulae in a patient with femoral hypoplasia due to Actinomyces europaeus and Actinomyces turicensis.

Authors:  A E Zautner; S Schmitz; C Aepinus; A Schmialek; A Podbielski
Journal:  Infection       Date:  2008-10-14       Impact factor: 3.553

9.  Characteristics of Arthrobacter cumminsii, the most frequently encountered Arthrobacter species in human clinical specimens.

Authors:  G Funke; M Pagano-Niederer; B Sjödén; E Falsen
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

10.  Actinomyces cardiffensis sp. nov. from human clinical sources.

Authors:  Val Hall; Mattew D Collins; Roger Hutson; Enevold Falsen; Brian I Duerden
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.